Headache. Other specified headache syndromes
Conditions
Interventions
Intervention 1: Subjects in control group will inhale 3 drops of placebo (liquid paraffin) poured on upper lip during 15 minutes. Intervention 2: Subjects in intervention group will inhale 3 drops of
Prevention
Subjects in control group will inhale 3 drops of placebo (liquid paraffin) poured on upper lip during 15 minutes.
Subjects in intervention group will inhale 3 drops of lavender oil 2% poured on upper lip during 15 minutes.
Sponsors
Vice chancellor for research, Qom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Having informed written consent for research participation; age of 18-60 years old; having complete consciousness; having no emergency conditions; having communication and speaking abilities; lack of being in delivery or near the delivery period (until 45 days after the delivery); having post dura puncture headache following spinal anesthesia; lack of seizures, history of migraine, tensional and other kinds of headaches, infection diseases (such as sinusitis or meningitis), intrathecal disorders, severe heart diseases and diabetes. Exclusion criteria: Unwillingness for study follow-up; having nausea and vomiting or other complications due to sever headache.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post dura puncture headache. Timepoint: Before intervention and immediately, 30, 60, 90, and 120 minutes after the intervention. Method of measurement: Visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of headache. Timepoint: Immediately after intervention. Method of measurement: Modified McGill quality of pain questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMeysam Hosseini Amiri
Qom University of Medical Sciences
Outcome results
None listed